Feature Channels:

Blood

Add to Favorites Subscribe Share
fbshare-Blood

Showing results

110 of 1236
Embargo will expire:
24-Jul-2019 9:00 AM EDT
Released to reporters:
19-Jul-2019 10:05 AM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 24-Jul-2019 9:00 AM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Channels:

All Journal News, Blood, Cancer, Diabetes

Languages:

English

coriell_logo_CMYK.jpg

Article ID: 716065

Coriell Institute for Medical Research Now a Collaborator in Prestigious Stand Up To Cancer Grant

Coriell Institute for Medical Research

The Coriell Institute for Medical Research is now participating in a prestigious SU2C Catalyst® grant from Stand Up To Cancer for the study of epigenetic therapy in treating urothelial cancer, a common form of cancer typically found in the bladder. Part of the project grant was moved to Coriell following its hiring of Jean-Pierre Issa, MD, as its new President and Chief Executive Officer.

Released:
19-Jul-2019 9:15 AM EDT
MSK_logo.png

Article ID: 716017

Cracking a Code: Landmark Prospective Study Helps Researchers Better Understand Which MGUS Patients Will Progress to a Multiple Myeloma Diagnosis

Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSK) researchers published new results that found that individuals with low-risk or intermediate-risk myeloma precursor disease known as monoclonal gammopathy of undetermined significance (MGUS) can convert to high-risk MGUS and progress to multiple myeloma within a five-year window. This research clinically supports recommendations for annual blood tests for all individuals diagnosed with MGUS along with re-assessments of a patient’s clinical-risk status.

Released:
18-Jul-2019 11:05 AM EDT
Newswise: Researchers Find Simple Way to Predict and Prevent Dangerous Blood Clots in Patients Treated for Multiple Myeloma

Article ID: 715939

Researchers Find Simple Way to Predict and Prevent Dangerous Blood Clots in Patients Treated for Multiple Myeloma

National Comprehensive Cancer Network® (NCCN®)

New research in JNCCN from the Hutchinson Institute for Cancer Outcomes Research (HICOR) within the Fred Hutch/University of Washington Cancer Consortium—part of the Seattle Cancer Care Alliance—identifies a simple way to help cancer doctors caring for patients with multiple myeloma to predict blood clots in order to take preventive action.

Released:
18-Jul-2019 9:35 AM EDT

Article ID: 716000

Burst Biologics publishes research on umbilical cord blood sourced allografts

Burst Biologics

Burst Biologics, a globally recognized institute in pharmaceutical research and tissue bank that services communities across the U.S., has published a research study entitled "Characterization of an umbilical cord blood sourced product suitable for allogeneic applications" in the prestigious peer-reviewed journal, Regenerative Medicine. This study is part of Burst Biologics' ongoing commitment to groundbreaking research.

Released:
18-Jul-2019 9:00 AM EDT
Newswise: The Medical Minute: From needle to vial, how blood work works

Article ID: 715993

The Medical Minute: From needle to vial, how blood work works

Penn State Health

Blood tests can diagnose disease, determine organ function and help your doctor see how well treatments are working. Here’s why they sometimes require so many samples – and why you can’t eat ahead of time.

Released:
18-Jul-2019 7:05 AM EDT
Newswise: $2M in Grants Drives Scientific Exploration of Rare Blood Cancer

Article ID: 715833

$2M in Grants Drives Scientific Exploration of Rare Blood Cancer

Rutgers Cancer Institute of New Jersey

More than $2 million in grants recently awarded to a Rutgers Cancer Institute of New Jersey resident researcher will support examination of potential treatment targets for T-cell acute lymphoblastic leukemia (T-ALL).

Released:
17-Jul-2019 8:00 AM EDT
Newswise: Lifetime Achievement award tops decades of work with patients and cancer groups

Article ID: 715915

Lifetime Achievement award tops decades of work with patients and cancer groups

UT Southwestern Medical Center

Dr. Phil Evans was honored with National Breast Cancer Foundation's Lifetime Achievement Award.

Released:
16-Jul-2019 4:05 PM EDT

Channels:

Blood, Cancer

Languages:

English

Article ID: 715752

Blood collection is digitalized, the mobile medical lab is born!

71st AACC Annual Scientific Meeting Press Program

80% of the world’s population has limited access to testing laboratories. Part of that problem is being addressed by mobile blood collection services done by independent professionals. For example, in US this blood collection service is being provided by independent mobile phlebotomy organizations.

Released:
12-Jul-2019 2:45 PM EDT

Showing results

110 of 1236

Chat now!